Teladoc Health Inc
F:4LL
Teladoc Health Inc
F:4LL
Price:
6.034
EUR
-1.05%
Market Closed
Market Cap:
€1B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
T
|
Teladoc Health Inc
F:4LL
|
US |
|
C
|
Conagra Brands Inc
XMUN:CAO
|
US |
|
V
|
Voya Financial Inc
F:V0Y
|
US |
|
M
|
MKS Instruments Inc
XMUN:MKT
|
US |
|
N
|
NWS Holdings Ltd
F:NWS
|
HK |
|
I
|
Innate Pharma SA
SWB:IDD
|
FR |
|
O
|
Oil States International Inc
SWB:OI2
|
US |
|
A
|
Ad Pepper Media International NV
XMUN:APM
|
DE |
|
Chewy Inc
F:3HH
|
US |
|
I
|
IDT Corp
XMUN:IDC2
|
US |
|
Grupo Mexico SAB de CV
F:4GE
|
MX |
|
L
|
Lagardere SA
DUS:LAG
|
FR |
|
I
|
IDT Corp
F:IDC2
|
US |
Wall St Price Targets
4LL Price Targets Summary
Teladoc Health Inc
Teladoc Health Inc
Wall Street analysts forecast 4LL stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for 4LL is 8.022 EUR with a low forecast of 5.636 EUR and a high forecast of 11.717 EUR.
Lowest Forecast
Price Target
5.636
EUR
7% Downside
Average Forecast
Price Target
8.022
EUR
33% Upside
Highest Forecast
Price Target
11.717
EUR
94% Upside
Teladoc Health Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 4LL's stock price target?
Price Target
8.022
EUR
8.022
EUR
According to Wall Street analysts, the average 1-year price target for 4LL is 8.022 EUR with a low forecast of 5.636 EUR and a high forecast of 11.717 EUR.
What is the Revenue forecast for Teladoc Health Inc?
Projected CAGR
2%
2%
Over the last 11 years, the compound annual growth rate for Revenue has been 45%. The projected CAGR for the next 6 years is 2%.
